Covid-19 Pandemic: An Opportunity for Indian Pharma Industry

 Are you wanting to enter into pharma manufacturing or confronting issues with your pharmaceutical manufacturing organization? Join SolutionBuggy and get help from expert pharma consultants who can guide in tackling your business problems.

India is the largest generic drug provider in the world. India supplies over 50 percent of antibodies across the globe and meets 40 percent of generic drug demand in the USA. Indian pharma organizations are notable for their affordable generic drug production. The pharmaceutical industry in India has made some amazing progress from its budding stage in the early 1960s supporting the dominance of foreign organizations to turning into a key contributor to the country's economy meeting both domestic and worldwide medical requirements. The Indian pharma industry has been assuming an important role in sparing the lives of millions in the world and improving the world wellbeing. The Indian pharma industry is expected to become USD 100 billion by 2025.

While numerous industries are struggling due to coronavirus outbreak and the ensuing lockdown imposed in the country, Indian pharma organizations are seeing a steady growth in the critical occasions of Covid-19 pandemic. Indian pharmaceutical organizations have been instrumental in combatting the virus with their enormous potential for the gracefully of medicals and generic drugs.

The Indian pharma industry, however, additionally has impediments that are viewed as a reason for concern. Attributable to the cross country lockdown that has disrupted the gracefully chain across the country the prices of raw materials and other key ingredients are rising, testing the production of medicines. Likewise, closure of factories in China on which India depends for a large number of APIs and KSMs required for the manufacture of generic drugs has adversely impacted pharma organizations in the country. In addition to the price climbs, inter-state transport and disruptions in the labor market due to migrations are other major difficulties of the pharma industry in the country.

Despite the afore-mentioned issues, the Indian pharma has an enormous potential to scale higher than ever over the long haul. The Covid-19pandemic has caused a severe loss of reputation to China, the epicenter of coronavirus in the worldwide market. Subsequently, a large number of organizations are looking towards India as a credible and the best alternative to China for the manufacturing of goods. The abundant accessibility of modest labor is another advantage to India over other countries. Considering the progressing pandemic circumstance across the world, wellbeing awareness is increasing rapidly among the individuals which thusly will increase the demand for medicines. Indian pharma industry given its proven expertise in terms of large-scale and savvy manufacturing of generic drugs, should leverage this opportunity immediately by acting admirably.

Be that as it may, for the Indian pharma industry to dominate and reach new statures by underwriting the current circumstance, it should limit dependency on the imports of APIs and other intermediaries from China. India currently imports over 70 percent of APIs which generally comprises of anti-microbials and nutrients form China, according to the Trade Promotion Council of India. In 2018-19 alone Indian pharma organizations imported APIs worth of USD 2.4 billion from China. The government is likewise taking required measures to encourage neighborhood organizations for the domestic manufacture of APIs. Indian pharma organizations should zero in on research and development of APIs and generic drugs to remain relevant in the exceptionally serious market.

On the off chance that you are a first-generation entrepreneur wanting to arrangement a pharmaceutical organization or a current industry confronting issues with your business, searching for pharma consultants who can provide you important advice and help on your particular requirements, at that point SolutionBuggy is your perfect aid.

SolutionBuggy, India's idea leader in the manufacturing sector provides you admittance to experienced pharma consultants who can assist you with setting up the industry and address various issues right from market research, plant arrangement, compliance and validation ,mass drugs and API manufacturing to bundling and certification.

A pharmaceutical manufacturing organization from Thane, Maharashtra was searching for consultants who can help them in the formulation of surgical spirit. SolutionBuggy helped them formulate the surgical spirit and dispatch the product into the market effectively. Till date, SolutionBuggy completed more than 270 pharma counseling projects.